Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUPPRES: Early Plasma for Hemorrhagic Shock in Emergency Surgery
NCT01221389Phase 4Withdrawn
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Mar 2012
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
- Countries
- 1
01
Overview
A Phase 4 trial of Fresh Frozen Plasma in hemorrhagic shock, sponsored by Ottawa Hospital Research Institute. Planned start Mar 2012; status: withdrawn.
02
Drugs
Fresh Frozen Plasma
03
Conditions
hemorrhagic shock
Beyond the preview
Go deeper on NCT01221389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01221389.